1.Bartlett, JG, et al. Antibiotic-associated pseudomembranous colitis due to toxin producing clostridia. New England Journal of Medicine 1978; 298: 531–534.
2.Spencer, RC. Clinical impact and associated costs of Clostridium difficile-associated disease. Journal of Antimicrobial Chemotherapy 1998; 41: 5–12.
3.McEllistrem, MC, et al. A hospital outbreak of Clostridium difficile disease associated with isolates carrying binary toxin genes. Clinical Infectious Diseases 2005; 40: 265–272.
4.Bauer, MP, et al. Clostridium difficile infection in Europe: a hospital-based survey. Lancet. 2011; 377: 63–73.
5.Cheng, VC, et al. Clostridium difficile isolates with increased sporulation: emergence of PCR ribotype 002 in Hong Kong. European Journal of Clinical Microbiology & Infectious Diseases 2011; 30: 1371–1381.
6.Huang, H, et al. Clostridium difficile infections in a Shanghai hospital: antimicrobial resistance, toxin profiles and ribotypes. International Journal of Antimicrobial Agents 2009; 33: 339–342.
7.Bishara, J, et al. Molecular epidemiology of Clostridium difficile in a tertiary medical center in Israel: emergence of the polymerase chain reaction ribotype O27. Israel Medical Association Journal 2011; 13: 338–341.
8.Maiden, MC. Multilocus sequence typing of bacteria. Annual Review of Microbiology 2006; 60: 561–588.
9.Griffiths, D, et al. Multilocus sequence typing of Clostridium difficile. Journal of Clinical Microbiology 2010; 48: 770–778.
10.Kato, H, et al. Identification of toxin A-negative, toxin B-positive Clostridium difficile by PCR. Journal of Clinical Microbiology 1998; 36: 2178–2182.
11.Lemée, L, et al. Multiplex PCR targeting tpi (triose phosphate isomerase), tcdA (toxin A), and tcdB (toxin B) genes for toxigenic culture of Clostridium difficile. Journal of Clinical Microbiology 2004; 42: 5710–5714.
12.Lemée, L, Pons, JL. Multilocus sequence typing for Clostridium difficile. Methods in Molecular Biology 2010; 646: 77–90.
13.Dingle, KE, et al. Clinical Clostridium difficile: clonality and pathogenicity locus diversity. PLoS One 2011; 6: e19993.
14.Cheng, Y, et al. Toxin A-negative, Toxin B-positive Clostridium difficile infection diagnosed by PCR. Infection Control and Hospital Epidemiology 2011; 32: 520–522.